Current Gastroenterology Reports

, Volume 8, Issue 3, pp 248–253

Genetic issues in pediatric pancreatitis

Article

Abstract

The number of hospitalizations in children with acute and chronic pancreatitis is increasing and accounts for significant morbidity. Acute pancreatitis is a reversible event involving diffuse inflammation of the pancreas with variable involvement of other regional tissues, remote organs, or both, whereas chronic pancreatitis is a process that produces irreversible changes in the pancreatic structure and function. Mutations in the gene encoding cationic trypsinogen have recently been identified to be associated with hereditary pancreatitis. Genetic mutations in the pancreatic secretory trypsin inhibitor and the cystic fibrosis transmembrane conductance regulator have been described to play a role in the development of pancreatitis as well. Mutations in the cytokine target genes relating to regulation of inflammation are likely to be important in determining the severity of pancreatitis. These findings, along with the advances in cell biology, have contributed to a better understanding of the pathophysiology of pancreatic diseases.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Whitcomb DC, Gorry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141–145. These authors first described the association of cationic trypsinogen mutations with hereditary pancreatitis.PubMedCrossRefGoogle Scholar
  2. 2.
    Rinderknecht H: Pancreatic secretory enzymes. In The Pancreas: Biology, Pathobiology, and Disease. New York: Raven Press; 1993:219–251.Google Scholar
  3. 3.
    Whitcomb DC: Early trypsinogen activation in acute pancreatitis. Gastroenterology 1999, 116:770–773.Google Scholar
  4. 4.
    Frossard JL, Past CM: Experimental acute pancreatitis: new insights into pathophysiology. Front Biosci 2002, 7:275–287.CrossRefGoogle Scholar
  5. 5.
    Fernandez-del Castillo C, Schmidt J, Warshaw AL, Rattner DW: Interstitial protease activation is the central event in progression to necrotizing pancreatitis. Surgery 1994, 116:497–504.PubMedGoogle Scholar
  6. 6.
    Cavallini G, Tittobello A, Frulloni L, et al.: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996, 335:919–923.PubMedCrossRefGoogle Scholar
  7. 7.
    Whitcomb DC: Genetic predisposition to acute and chronic pancreatitis. Med Clin North Am 2000, 84:531–547. This review covers the evidence for the role of genetic mutations in acute and chronic pancreatitis.PubMedCrossRefGoogle Scholar
  8. 8.
    Whitcomb DC: Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut 1999, 45:317–322.PubMedCrossRefGoogle Scholar
  9. 9.
    Ward JB, Peterson OH, Jenkins SA, Sutton R: Is an elevated concentration of acinar cytosolic free ionized calcium the trigger for acute pancreatitis? Lancet 1995, 346:1016–1019.PubMedCrossRefGoogle Scholar
  10. 10.
    Gorry MC, Gabbaizedeh D, Furey W, et al.: Multiple mutations in the cationic trypsinogen gene are associated with hereditary pancreatitis. Gastroenterology 1997, 113:1063–1068.PubMedCrossRefGoogle Scholar
  11. 11.
    Schneider A, Whitcomb DC: Hereditary pancreatitis: a model for inflammatory diseases of the pancreas. Best Pract Res Clin Gastroenterol 2002, 16:347–363. This review discusses the genetic studies on kindreds with HP and reviews the theories on development of chronic pancreatitis.PubMedCrossRefGoogle Scholar
  12. 12.
    Comfort M, Steinberg A: Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952, 21:54–63.PubMedGoogle Scholar
  13. 13.
    Khalid A, Finkelstein S, Thompson B, et al.: A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression and without pancreatitis: insights into phenotypic non-penetrance. Gut 2005. Dec 14; [Epub ahead of print].Google Scholar
  14. 14.
    Amann ST, Gates LK, Aston CE, et al.: Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins. Gut 2001, 48:542–547.PubMedCrossRefGoogle Scholar
  15. 15.
    Sibert JR: Hereditary pancreatitis in England and Wales. J Med Genet 1978, 15:189–201.PubMedCrossRefGoogle Scholar
  16. 16.
    Keim V, Bauer N, Teich N, et al.: Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 2001, 111:622–626.PubMedCrossRefGoogle Scholar
  17. 17.
    Kattwinkel J, Lapey A, Di Sant’Agnese PA, Edwards WA: Hereditary pancreatitis: three new kindreds and a critical review of the literature. Pediatrics 1973, 51:55–69.PubMedGoogle Scholar
  18. 18.
    Elitsur Y, Hunt JA, Chertow BS: Hereditary pancreatitis in the children of West Virginia. Pediatrics 1994, 93:528–531.PubMedGoogle Scholar
  19. 19.
    Witt H: Gene mutations in children with chronic pancreatitis. Pancreatology 2001, 1:432–438.PubMedCrossRefGoogle Scholar
  20. 20.
    Oralewska B, Oracz G, Sobczynska-Tomaszewska A, et al.: Hereditary pancreatitis in children: SY1-02. J Pediatr Gastroenterol Nutr 2005, 40:630.Google Scholar
  21. 21.
    Konzen KM, Perrault J, Moir C, Zinsmeister AR: Long-term follow-up of young patients with chronic hereditary or idiopathic pancreatitis. Mayo Clin Proc 1993, 68:449–453.PubMedGoogle Scholar
  22. 22.
    Howes N, Lerch MM, Greenhalf W, et al.: Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004, 2:252–261. An excellent long-term follow-up study of patients with HP.PubMedCrossRefGoogle Scholar
  23. 23.
    Witt H, Luck W, Hennies HC, et al.: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000, 25:213–216.PubMedCrossRefGoogle Scholar
  24. 24.
    Pfutzer RH, Barmada MM, Brunskill AP, et al.: SPINK1/ PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000, 119:615–623.PubMedCrossRefGoogle Scholar
  25. 25.
    Chen JM, Mercier B, Audrezet MP, et al.: Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis. Gastroenterology 2001, 120:1061–1064.PubMedCrossRefGoogle Scholar
  26. 26.
    Plendl H, Siebert R, Steinemann D, Grote W: High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay. Am J Med Genet 2001, 100:252–253.PubMedCrossRefGoogle Scholar
  27. 27.
    Rossi L, Pfutzer RH, Parvin S, et al.: SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report. Pancreatology 2001, 1:242–245. SPINK1 mutations in children with tropical pancreatitis were first described in this paper.PubMedCrossRefGoogle Scholar
  28. 28.
    Whitcomb DC: Value of genetic testing in the management of pancreatitis. Gut 2004, 53:1710–1717. Excellent review of the role of genetic factors in the development of pancreatitis. The author provides possible mechanisms of recurrent acute and chronic pancreatitis in the context of heterozygous CFTR mutations.PubMedCrossRefGoogle Scholar
  29. 29.
    del Rosario JF, Putnam PE, Orenstein DM: Chronic pancreatitis in a patient with cystic fibrosis and clinical pancreatic insufficiency. J Pediatr 1995, 126:951–952.PubMedCrossRefGoogle Scholar
  30. 30.
    De Boeck K, Weren M, Proesmans M, Kerem E: Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 2005, 115:463–469. This recent study describes the occurrence and outcomes of pancreatitis in both pancreatic-sufficient and pancreatic-insufficient patients with CF.CrossRefGoogle Scholar
  31. 31.
    Durno C, Corey M, Zielenski J, et al.: Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002, 123:1857–1864.PubMedCrossRefGoogle Scholar
  32. 32.
    Zielenski J, Tsui LC: Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 1995, 29:777–807.PubMedCrossRefGoogle Scholar
  33. 33.
    Atlas AB, Orenstein SR, Orenstein DM: Pancreatitis in young children with cystic fibrosis. J Pediatr 1992, 120:756–759.PubMedCrossRefGoogle Scholar
  34. 34.
    Durie, PR: Pancreatitis and mutations of the cystic fibrosis gene. N Engl J Med 1998, 339:687–688.PubMedCrossRefGoogle Scholar
  35. 35.
    Shwachman H, Lebenthal E, Khaw KT: Recurrent acute pancreatitis in patients with cystic fibrosis with normal pancreatic enzymes. Pediatrics 1975, 55:86–95.PubMedGoogle Scholar
  36. 36.
    Cohn JA, Friedman KJ, Noone PG, et al.: Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653–658.PubMedCrossRefGoogle Scholar
  37. 37.
    Sharer N, Schwarz M, Malone G, et al.: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998, 339:645–652.PubMedCrossRefGoogle Scholar
  38. 38.
    Pezzilli R, Morselli-Labate AM, Mantovani V, et al.: Mutations of the CFTR gene in pancreatic disease. Pancreas 2003, 27:332–336.PubMedCrossRefGoogle Scholar
  39. 39.
    Noone PG, Zhou Z, Silverman LM, et al.: Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations. Gastroenterology 2001, 121:1310–1319. This paper shows that the combination of two CFTR mutations and a SPINK1 mutation increases the risk of pancreatitis 900-fold.PubMedCrossRefGoogle Scholar
  40. 40.
    Beranek H, Teich N, Witt H, et al.: Analysis of tumour necrosis factor alpha and interleukin 10 promotor variants in patients with chronic pancreatitis. Eur J Gastroenterol Hepatol 2003, 15:1223–1227.PubMedCrossRefGoogle Scholar
  41. 41.
    Zhang D, Li J, Jiang ZW, et al.: Association of two polymorphisms of tumor necrosis factor gene with acute severe pancreatitis. J Surg Res 2003, 112:138–143.PubMedCrossRefGoogle Scholar
  42. 42.
    Papachristou GI, Sass DA, Avula H, et al.: Is the monocyte chemotactic protein-1 -2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005, 3:475–481.PubMedCrossRefGoogle Scholar
  43. 43.
    Van Laethem JL, Eskinazi R, Louis H, et al.: Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 1998, 43:408–413.PubMedCrossRefGoogle Scholar
  44. 44.
    Han XC, Zhang YC, Wang Y, Jia MK: Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int 2003, 2:135–138.PubMedGoogle Scholar
  45. 45.
    Ellis I, Lerch MM, Whitcomb DC et al.: Genetic testing for hereditary pancreatitis: guidelines for indications, counseling, consent and privacy issues. Pancreatology 2001, 1:405–415. This paper provides a good overview of the many issues related to genetic testing.PubMedCrossRefGoogle Scholar
  46. 46.
    Whitcomb DC: Motion-genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments for the motion. Can J Gastroenterol 2003, 17:47–52.PubMedGoogle Scholar
  47. 47.
    Cohn JA: Motion-genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments against the motion. Can J Gastroenterol 2003, 17:53–55.PubMedGoogle Scholar
  48. 48.
    Applebaum SE, Kant JA, Whitcomb DC, Ellis IH: Genetic testing: Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am 2000, 84:575–588.PubMedCrossRefGoogle Scholar
  49. 49.
    Ellis I: Genetic counseling for hereditary pancreatitis: the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type I. Gastroenterol Clin N Am 2004, 33:839–854.CrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • Leena Kandula
  • David C. Whitcomb
  • Mark E. Lowe
    • 1
  1. 1.Department of PediatricsChildren’s Hospital of PittsburghPittsburghUSA

Personalised recommendations